Jasper Therapeutics Inc (JSPR) Stock Analysis

Jasper Therapeutics Inc (JSPR) is a publicly traded company in the HEALTHCARE sector. It trades at $0.55, carries a market capitalization of $22.82M. This page summarizes the public market data, fundamentals, and frequently asked questions for JSPR, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $0.55
• Market Cap: $22.82M
• EPS: $-2.58
• 52-Week High: $7.19
• 52-Week Low: $0.53

Market Sentiment

Jasper Therapeutics Inc currently has a Bearish sentiment score of -0.35.

About Jasper Therapeutics Inc

None

GNG Research Analysis

GNG Research scores Jasper Therapeutics Inc (JSPR) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for JSPR.

Frequently Asked Questions

Does JSPR pay dividends?

Jasper Therapeutics Inc (JSPR) does not currently pay a regular dividend.

What is JSPR's market cap?

Jasper Therapeutics Inc (JSPR) has a market capitalization of $22.82M with a current stock price of $0.55.